Related Articles
Treatment of etoposide combined with 15-deoxy‑∆12,14‑prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferator‑activated receptor‑γ‑independent pathways
Novel SIRT1 inhibitor 15-deoxy-Δ12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells
Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells
The peroxisome proliferator-activated receptor γ ligand 15-deoxy-Δ12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637
The PPARγ ligand, 15-Deoxy-Δ12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells